Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Guger

Oral Therapies for Treatment of Relapsing–remitting Multiple Sclerosis in Austria: A 2-Year Comparison Using an Inverse Probability Weighting Method

Journal of Neurology

English

Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry

Journal of Neurology

English

Related publications

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment

Biological Psychiatry

English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management

Chemical Health

Safety Research

English

No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis

Advances in Therapy

English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics

English

Emerging Therapies for Relapsing Multiple Sclerosis

Archives of Neurology

English

A Type 2 Biomarker Separates Relapsing-Remitting From Secondary Progressive Multiple Sclerosis

English

Intravenous Immunoglobulin G for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis

European Journal of Neurology

English

PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

Value in Health

Occupational Health

English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology

English